AbbVie (ABBV) Finished Goods (2012 - 2016)

AbbVie (ABBV) has reported Finished Goods for 5 consecutive years, with $556.0 million the latest figure, recorded in Q2 2016.

• On a quarterly basis, Finished Goods rose 16.32% year-over-year to $556.0 million in Q2 2016; TTM through Jun 2016 was $556.0 million, a 16.32% increase from a year earlier, with the FY2015 full-year figure at $469.0 million, up 37.54% from the prior year.
• Finished Goods was $556.0 million for Q2 2016 at AbbVie, up from $552.0 million in the prior quarter.
• Over five years, Finished Goods peaked at $640.0 million in Q3 2015 and troughed at $280.0 million in Q3 2014.
• A 5-year average of $479.5 million and a median of $485.0 million in 2013 frame the typical range for Finished Goods.
• Across the five-year window, Finished Goods sank 41.42% in 2014 and soared 128.57% in 2015, its largest moves.
• Over 5 years, Finished Goods stood at $547.0 million in 2012, then slipped by 11.33% to $485.0 million in 2013, then retreated by 29.69% to $341.0 million in 2014, then surged by 37.54% to $469.0 million in 2015, then increased by 18.55% to $556.0 million in 2016.
• The last three Finished Goods figures came in at $556.0 million (Q2 2016), $552.0 million (Q1 2016), and $469.0 million (Q4 2015), per Business Quant data.